Antisense oligonucleotides inhibit in vitro cDNA synthesis by HIV-1 reverse transcriptase

Area of Science:

• Biochemistry
• Molecular Biology
• Antiviral Drug Discovery

Background:

• Reverse transcription is a critical step in the HIV-1 replication cycle.
• Antisense oligonucleotides (ASOs) are a promising class of antiviral agents.
• Understanding the mechanisms of ASO inhibition is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the mechanisms by which chemically modified antisense oligonucleotides inhibit HIV-1 reverse transcriptase (RT).
• To evaluate the impact of different chemical modifications on ASO efficacy and inhibitory mechanisms.

Main Methods:

• A cell-free system was utilized, comprising an RNA template, a primer oligodeoxynucleotide, and purified HIV-1 RT.
• Various chemically modified ASOs, including 2'-O-allyl, phosphodiester, phosphorothioate, chimeric, alpha, and methylphosphonate oligonucleotides, were tested.
• Inhibition mechanisms were elucidated by analyzing polymerase activity and RNA cleavage.

Main Results:

• 2'-O-allyl oligonucleotides physically arrested the polymerase.
• Phosphodiester and phosphorothioate oligonucleotides induced RNase H-mediated RNA cleavage.
• Phosphorothioate oligonucleotides also demonstrated direct enzyme interaction.
• Chimeric oligonucleotides showed reduced efficiency compared to unmodified counterparts.
• Alpha and methylphosphonate oligomers exhibited no inhibitory effect.

Conclusions:

• The chemical structure of antisense oligonucleotides dictates their mechanism of HIV-1 RT inhibition.
• RNase H-mediated cleavage and direct enzyme interaction are key mechanisms for effective inhibition.
• Certain chemical modifications, such as alpha and methylphosphonate, are not effective against HIV-1 RT in this system.